Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-11-11
2009-12-01
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S266210, C514S266230, C514S266300, C514S255050, C544S284000, C544S293000
Reexamination Certificate
active
07625908
ABSTRACT:
A quinazoline derivative of the Formula (I): wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm-blooded animal such as man.
REFERENCES:
patent: 4322420 (1982-03-01), Kobayashi et al.
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 4640920 (1987-02-01), Boyle et al.
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 5405843 (1995-04-01), Fukazawa et al.
patent: 5721237 (1998-02-01), Myers et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5929080 (1999-07-01), Frost
patent: 5962458 (1999-10-01), Lohmann et al.
patent: 6004967 (1999-12-01), McMahon et al.
patent: 6046206 (2000-04-01), Pamukcu et al.
patent: 6117433 (2000-09-01), Edens et al.
patent: 6297258 (2001-10-01), Wissner et al.
patent: 6313130 (2001-11-01), Uckun et al.
patent: 6326373 (2001-12-01), Uckun et al.
patent: 6384223 (2002-05-01), Gletsos
patent: 6562319 (2003-05-01), Mishani et al.
patent: 6972288 (2005-12-01), Himmelsbach et al.
patent: 7148230 (2006-12-01), Bradbury et al.
patent: 2002/0082270 (2002-06-01), Himmelsbach et al.
patent: 2002/0128553 (2002-09-01), Mishani et al.
patent: 2003/0186995 (2003-10-01), Kath et al.
patent: 2004/0048880 (2004-03-01), Himmelsbach et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 2005/0043336 (2005-02-01), Hennequin et al.
patent: 2005/0054662 (2005-03-01), Hennequin et al.
patent: 2005/0215574 (2005-09-01), Bradbury et al.
patent: 2006/0211714 (2006-09-01), Hennequin et al.
patent: 2006/0287295 (2006-12-01), Barlaam et al.
patent: 2007/0015743 (2007-01-01), Bradbury et al.
patent: 2007/0032508 (2007-02-01), Bradbury et al.
patent: 2007/0032513 (2007-02-01), Hennequin et al.
patent: 2007/0037837 (2007-02-01), Hennequin et al.
patent: 2007/0043009 (2007-02-01), Hennequin et al.
patent: 2007/0043010 (2007-02-01), Bradbury et al.
patent: 2007/0082921 (2007-04-01), Hennequin et al.
patent: 2007/0088044 (2007-04-01), Hennequin et al.
patent: 2007/0099943 (2007-05-01), Bradbury et al.
patent: 2007/0149546 (2007-06-01), Bradbury et al.
patent: 2007/0232607 (2007-10-01), Bradbury et al.
patent: 2007/0293490 (2007-12-01), Delouvrie et al.
patent: 2476008 (2003-10-01), None
patent: 2543649 (2005-05-01), None
patent: 0288563 (1988-11-01), None
patent: 0 566 226 (1995-11-01), None
patent: 0 602 851 (1996-10-01), None
patent: 0 520 722 (1996-12-01), None
patent: 0 787 722 (1997-08-01), None
patent: 0 837 063 (1998-04-01), None
patent: 0 326 330 (2002-07-01), None
patent: 1230919 (2002-08-01), None
patent: 1369418 (2003-12-01), None
patent: 2295387 (1966-05-01), None
patent: 08-003144 (1996-01-01), None
patent: 11-189586 (1999-07-01), None
patent: WO 88/02365 (1988-04-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO 93/08170 (1993-04-01), None
patent: WO 93/17682 (1993-09-01), None
patent: WO 95/15758 (1995-06-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/15118 (1996-05-01), None
patent: WO 96/16960 (1996-06-01), None
patent: WO 96/30347 (1996-10-01), None
patent: WO 96/33977 (1996-10-01), None
patent: WO 96/33978 (1996-10-01), None
patent: WO 96/33979 (1996-10-01), None
patent: WO 96/33980 (1996-10-01), None
patent: WO 96/33981 (1996-10-01), None
patent: WO 96/39145 (1996-12-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 97/11692 (1997-04-01), None
patent: WO 97/13771 (1997-04-01), None
patent: WO 97/22596 (1997-06-01), None
patent: WO 97/30034 (1997-08-01), None
patent: WO 97/30035 (1997-08-01), None
patent: WO 97/30044 (1997-08-01), None
patent: WO 97/38983 (1997-10-01), None
patent: WO 97/38994 (1997-10-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/02437 (1998-01-01), None
patent: WO 98/02438 (1998-01-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 98/38984 (1998-09-01), None
patent: WO 98/50038 (1998-11-01), None
patent: WO 98/50370 (1998-11-01), None
patent: WO 99/06378 (1999-02-01), None
patent: WO 99/09016 (1999-02-01), None
patent: WO 99/24037 (1999-05-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 99/61428 (1999-12-01), None
patent: WO 00/00202 (2000-01-01), None
patent: WO 00/06555 (2000-02-01), None
patent: WO 00/09481 (2000-02-01), None
patent: WO 00/10981 (2000-03-01), None
patent: WO 00/18740 (2000-04-01), None
patent: WO 00/20402 (2000-04-01), None
patent: WO 00/24718 (2000-05-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 00/51587 (2000-09-01), None
patent: WO 00/51991 (2000-09-01), None
patent: WO 00/55141 (2000-09-01), None
patent: WO 00/73260 (2000-12-01), None
patent: WO 01/07432 (2001-02-01), None
patent: WO 01/12227 (2001-02-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21595 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/32632 (2001-05-01), None
patent: WO 01/45641 (2001-06-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 01/94341 (2001-12-01), None
patent: WO 01/98277 (2001-12-01), None
patent: WO 02/18372 (2002-03-01), None
patent: WO 02/24684 (2002-03-01), None
patent: WO 02/30924 (2002-04-01), None
patent: WO 02/34744 (2002-05-01), None
patent: WO 02/41882 (2002-05-01), None
patent: WO 02/44166 (2002-06-01), None
patent: WO 02/48117 (2002-06-01), None
patent: WO 02/056882 (2002-07-01), None
patent: WO 02/062767 (2002-08-01), None
patent: WO 02/066445 (2002-08-01), None
patent: WO 02/068409 (2002-09-01), None
patent: WO 02/073235 (2002-09-01), None
patent: WO 02/076976 (2002-10-01), None
patent: WO 02/092577 (2002-11-01), None
patent: WO 02/092578 (2002-11-01), None
patent: WO 02/094790 (2002-11-01), None
patent: WO 03/040108 (2003-05-01), None
patent: WO 03/040109 (2003-05-01), None
patent: WO 03/049740 (2003-06-01), None
patent: WO 03/082290 (2003-10-01), None
patent: WO 03/082831 (2003-10-01), None
patent: WO 2004/006846 (2004-01-01), None
patent: WO 2004/046101 (2004-06-01), None
patent: WO 2004/064718 (2004-08-01), None
patent: WO 2004/093880 (2004-11-01), None
patent: WO 2004/096226 (2004-11-01), None
patent: WO 2005/012290 (2004-11-01), None
patent: WO 2005/013998 (2005-02-01), None
patent: WO 2005/026150 (2005-03-01), None
patent: WO 2005/026151 (2005-03-01), None
patent: WO 2005/026152 (2005-03-01), None
patent: WO 2005/026156 (2005-03-01), None
patent: WO 2005/026157 (2005-03-01), None
patent: WO 2005/028469 (2005-03-01), None
patent: WO 2005/028470 (2005-03-01), None
patent: WO 2005/030757 (2005-04-01), None
patent: WO 2005/030765 (2005-04-01), None
patent: WO 2005/041973 (2005-05-01), None
patent: WO 2005/075439 (2005-08-01), None
patent: WO 2005/097134 (2005-10-01), None
patent: WO 2005/118572 (2005-12-01), None
patent: WO 2006/008526 (2006-01-01), None
patent: WO 2006/064196 (2006-06-01), None
patent: WO 2006/090163 (2006-08-01), None
patent: WO 2006/092573 (2006-09-01), None
patent: WO 2006/092574 (2006-09-01), None
patent: WO 2006/117521 (2006-11-01), None
patent: WO 2006/117523 (2006-11-01), None
patent: WO 2007/034143 (2007-03-01), None
patent: WO 2007/034144 (2007-03-01), None
patent: WO 2007/063291 (2007-06-01), None
patent: WO 2007/063293 (2007-06-01), None
Grunwald, V. et. al., “Developing Inhibitors . . . for Cancer Treatment”, Review, J. Nat. Can. Inst., (Jun. 18, 2003) vol. 95, No. 12, pp. 851-867.
Ballard et al. “5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase” Bioorg Med Chem Lett. 15(19):4226-4229 (2005).
Ballard et al. “Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket” Bioorg Med Chem Lett. 16(6):1633-1637 (2006).
Barker et al. “Studies leading to the identification of ZD1839 (Iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer”Bioorganic an
Bradbury Robert Hugh
Hennequin Laurent Francois Andre
Kettle Jason Grant
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Truong Tamthom N
Wilson James O
LandOfFree
Quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099508